rheumatoid factor-negative juvenile idiopathic arthritis with anti-nuclear antibodies

ORPHA: 2478544 Treatments Available

Contents

Overview

human disease

Drug	Form	Status	Countries	Lead Time
etanercept Cold Chain	subcutaneous injection 25mg, 50mg prefilled syringe; 50mg/mL autoinjector	FDA Approved	10	10d
tocilizumab Cold Chain	IV infusion 20mg/mL; subcutaneous injection 162mg/0.9mL	FDA Approved, EMA Approved	10	7d
adalimumab Cold Chain	subcutaneous injection 40mg/0.8mL, 20mg/0.4mL prefilled syringe	FDA Approved	9	14d
Methotrexate Orphan	Oral tablet 2.5mg, 5mg, 7.5mg, 10mg, 15mg; Injectable solution 25mg/mL	FDA Approved	9	3d

Orphanet Code

ORPHA:247854

rheumatoid factor-negative juvenile idiopathic arthritis with anti-nuclear antibodies

Treatment Summary

Factual Authority

Last Updated3/20/2026

Clinical DataHPO · Orphanet

Drug DataFDA · EMA · CDSCO